Skip to main content
Premium Trial:

Request an Annual Quote

Element Biosciences: Edwin Hauw

Element Biosciences has appointed Edwin Hauw as senior VP of marketing and product management. He will also develop external partnerships and implement strategies to drive adoption of the firm's Aviti sequencer and future products. He comes to the firm from 10x Genomics, where he was VP of marketing. He also held product management roles at Pacific Biosciences, Applied Biosystems, and Affymetrix. Hauw holds an MBA from the University of Southern California. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.